International Business

Under a licensing agreement AbbVie, Pfizer will be able to launch its Humira biosimilar in the United States Nov. 20, 2023.

Procter & Gamble has completed its €3.2 billion acquisition of Darmstadt, Germany-based Merck KGaA’s consumer health business.

Global retail volume growth will be 2.8% in 2019, down from 2.9% predicted six months ago, as a result of the United States and China trade conflict, according to a report from The Economist Intelligence Unit.

Nutritional supplement maker Swanson Health is broadening its horizons, partnering with Azoya to launch a Chinese e-commerce site.

Kroger has unveiled the location of its first customer fulfillment center — an automated facility that will use digital and robotic capabilities and mark the first effort in the grocer’s partnership with U.K. online grocer Ocado.

The AAM is expressing opposition, along with 28 groups, over the U.S. Mexico-Canada Agreement for its potential to keep drug prices high.

Coty announced that Pierre Laubies will be taking over as its new CEO, in addition to its board appointing Peter Harf as chairman and Erhard Schowel as lead independent director.

Xellia is unveiling vancomycin hydrochloride for injection, which had a market value of $338 million, according to IQVIA.